This inventor holds 2 USPTO granted patents. Top assignee: Nanjing University. Active years: 2019-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2025
Title: Innovations of Qinchang Chen in Endocrine Disruptor Screening
Introduction
Qinchang Chen is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of endocrine disruptor screening, holding 2 patents that address critical issues in this area. His work focuses on developing innovative methods for identifying and predicting the effects of endocrine disruptors, which are chemicals that can interfere with hormonal systems.
Latest Patents
Qinchang Chen's latest patents include a model for high-throughput screening of endocrine disruptors and a method for screening thyroid hormone disruptors. The first patent provides a comprehensive model that utilizes primary, secondary, and tertiary structural alerts of compounds to effectively screen potential nuclear receptor-mediated endocrine disruptors. This invention overcomes previous limitations in high-throughput screening, allowing for a more efficient identification of harmful substances. The second patent relates to a method for qualitative identification and quantitative prediction of thyroid hormone disrupting chemicals. This method employs molecular dynamics simulations to classify chemicals as antagonists or agonists, enhancing the accuracy of disrupting potency predictions.
Career Highlights
Qinchang Chen is affiliated with Nanjing University, where he continues to advance research in the field of endocrine disruptors. His innovative approaches have garnered attention and recognition within the scientific community, contributing to a better understanding of the interactions between chemicals and hormonal systems.
Collaborations
Qinchang Chen has collaborated with esteemed colleagues such as Wei Shi and Hongxia Yu. These partnerships have facilitated the exchange of ideas and expertise, further enriching his research endeavors.
Conclusion
Qinchang Chen's contributions to the field of endocrine disruptor screening are invaluable. His innovative patents and collaborative efforts reflect a commitment to advancing scientific knowledge and improving public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile